When comparing intra-articular hyaluronic acid injections, numbers such as 1%, 2%, or 3% HA are frequently highlighted. However, concentration alone does not provide a complete picture of a hyaluronic acid formulation.
The total amount of HA, injection volume, molecular characteristics, cross-linking status, and rheological properties can all influence how a formulation behaves.
For this reason, products such as AlkaFlex Hyaluronic Acid should be evaluated according to their complete formulation rather than concentration alone.
Hyaluronic acid concentration describes the amount of HA contained within a specific volume of solution.
For example, increasing the concentration means that a greater amount of hyaluronic acid is present within the same volume.
However, concentration and total HA dose are not the same parameter. Two products may have different injection volumes while delivering different total quantities of hyaluronic acid.
When evaluating an intra-articular injection, healthcare professionals may consider both concentration and the total amount of hyaluronic acid delivered.
Important formulation characteristics include:
Therefore, comparing products solely by percentage can oversimplify meaningful differences between formulations.
Not necessarily.
A higher HA concentration does not automatically make one formulation clinically superior to another. The overall performance of a hyaluronic acid injection depends on several interconnected characteristics.
Clinical selection should therefore consider the complete formulation together with the patient's condition, treatment objectives, and physician assessment.
Another important distinction is whether the hyaluronic acid is cross-linked or linear.
Linear HA retains a molecular structure closer to native hyaluronic acid, whereas cross-linking creates connections between HA chains and modifies the physical characteristics of the formulation.
Consequently, two injections containing similar amounts of HA may still behave differently depending on their molecular structure and formulation.
AlkaFlex by Orthosyn Medikal offers different intra-articular hyaluronic acid formulations to provide alternatives for different clinical approaches.
The AlkaFlex portfolio includes linear and cross-linked HA formulations with different concentrations and total HA amounts, allowing healthcare professionals to select an appropriate option according to their clinical assessment.
AlkaFlex hyaluronic acid is produced using microbial fermentation, providing a non-animal-source HA platform.
HA concentration is an important characteristic of an intra-articular injection, but it should never be considered in isolation.
Concentration, total HA dose, injection volume, molecular characteristics, and cross-linking status should be evaluated together when comparing hyaluronic acid formulations.
The AlkaFlex portfolio provides multiple hyaluronic acid options designed to address different treatment strategies while giving healthcare professionals flexibility in product selection.